APA (7th ed.) Citation

GR, G., S, B., L, C., Y, C., N, F., HP, G., . . . J, C. (2021). Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program. Clinical pharmacology and therapeutics, 110(5), 1172. https://doi.org/10.1002/cpt.2265

Chicago Style (17th ed.) Citation

GR, Galluppi, et al. "Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program." Clinical Pharmacology and Therapeutics 110, no. 5 (2021): 1172. https://doi.org/10.1002/cpt.2265.

MLA (9th ed.) Citation

GR, Galluppi, et al. "Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot Program." Clinical Pharmacology and Therapeutics, vol. 110, no. 5, 2021, p. 1172, https://doi.org/10.1002/cpt.2265.